Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the con...
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
BioMed Central
2020
|
_version_ | 1826280916146716672 |
---|---|
author | Degaga, TS Weston, S Tego, TT Abate, DT Aseffa, A Wayessa, A Price, RN Hailu, A Thriemer, K |
author_facet | Degaga, TS Weston, S Tego, TT Abate, DT Aseffa, A Wayessa, A Price, RN Hailu, A Thriemer, K |
author_sort | Degaga, TS |
collection | OXFORD |
description | International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the context. The investigators of a multicentre anti-malarial clinical trial (the IMPROV study) conducted a dissemination meeting at one of the study sites in Ethiopia; trial participants and medical staff were provided feedback on the study results. This report summarizes the dissemination strategies adopted by the investigators, including a plain language visual aid and simple communication techniques. Lessons learned are reported with a discussion on the operational challenges to dissemination of clinical trials in resource limited settings. |
first_indexed | 2024-03-07T00:20:55Z |
format | Journal article |
id | oxford-uuid:7c80ed0c-88e7-4908-8a08-03f53b194174 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T00:20:55Z |
publishDate | 2020 |
publisher | BioMed Central |
record_format | dspace |
spelling | oxford-uuid:7c80ed0c-88e7-4908-8a08-03f53b1941742022-03-26T20:57:34ZDisseminating clinical study results to trial participants in Ethiopia: insights and lessons learnedJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7c80ed0c-88e7-4908-8a08-03f53b194174EnglishSymplectic ElementsBioMed Central2020Degaga, TSWeston, STego, TTAbate, DTAseffa, AWayessa, APrice, RNHailu, AThriemer, KInternational regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the context. The investigators of a multicentre anti-malarial clinical trial (the IMPROV study) conducted a dissemination meeting at one of the study sites in Ethiopia; trial participants and medical staff were provided feedback on the study results. This report summarizes the dissemination strategies adopted by the investigators, including a plain language visual aid and simple communication techniques. Lessons learned are reported with a discussion on the operational challenges to dissemination of clinical trials in resource limited settings. |
spellingShingle | Degaga, TS Weston, S Tego, TT Abate, DT Aseffa, A Wayessa, A Price, RN Hailu, A Thriemer, K Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned |
title | Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned |
title_full | Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned |
title_fullStr | Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned |
title_full_unstemmed | Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned |
title_short | Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned |
title_sort | disseminating clinical study results to trial participants in ethiopia insights and lessons learned |
work_keys_str_mv | AT degagats disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT westons disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT tegott disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT abatedt disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT aseffaa disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT wayessaa disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT pricern disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT hailua disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned AT thriemerk disseminatingclinicalstudyresultstotrialparticipantsinethiopiainsightsandlessonslearned |